Search filters

List of works by Jean-Luc Meynard

A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis

scientific article published on 01 January 2007

Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection

scientific article

Atazanavir urinary stones in an HIV-infected patient

scientific article published on 01 October 2006

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

scientific article published in September 2008

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)

scientific article published on 01 December 2019

Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors

scientific article published on 01 April 2006

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

scientific article published on May 2013

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

scientific article published on 01 January 2015

Factors predictive of virological failure on atazanavir in 310 HIV-infected patients

scientific article published in June 2010

Fanconi syndrome and renal failure induced by tenofovir: a first case report

scientific article published in December 2002

High variability of plasma drug concentrations in dual protease inhibitor regimens

scientific article published on March 2003

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels

article

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial

scientific article published in January 2010

Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial

article

Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients

scientific article published on January 2015

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

scientific article

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

scientific article

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

scientific article published on 23 January 2009

Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.

scientific article published on January 2010

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial ⬇️

scientific article published on September 15, 2010

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

scientific article published on 7 July 2017

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia

scientific article published on 5 September 2006

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

scientific article published on 01 March 2002

Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients

scientific article published on April 2012

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).

scientific article published in October 2003

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

scientific article published on 21 June 2016

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients

scientific article published in June 2010

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen

scientific article published in July 2005

Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults

scientific article published on 06 December 2019

Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir

scientific article published on 17 November 2008

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

scientific article published on 01 November 2018

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads

scientific article published on 01 November 2018

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

scientific article published on 01 June 2018

Paulina is supported by:

About Paulina

Help